Adora Tech L.L.C.

Advancing Disease Screening with AI-Powered Technology

Our Vision

At Adora Tech, we envision a future where advanced AI and scientific research make early disease detection accessible and reliable for all.

Our Mission


To integrate artificial intelligence, machine learning, and cutting-edge science into innovative platforms for early detection and prevention of life-threatening diseases.

What We Do

  • Develop AI/ML-driven platforms for early detection of GI cancers, lung cancers, PTSD, and Alzheimer’s disease.
  • Collaborate with top-tier research and clinical institutions to ensure accuracy and relevance.
  • Translate research into clinical applications with a strong focus on regulatory compliance and patient outcomes.
Tourist taking photo of a building

Our Technology

  • Disease Screening Platforms:
    • Integrating AI/ML with clinical data to predict early signs of diseases.
    • Utilizing advanced algorithms to detect cancer markers and PTSD indicators.
    • Scalable technology designed for use in both clinical and remote healthcare settings.
  • Key Innovations:
    • Machine learning models trained on diverse datasets for high sensitivity and specificity.
    • Biomarkers for non-invasive diagnostics.
    • Advanced data visualization tools for clinicians.

Our Team

Leadership
• Dr. Yichao Yang, Ph.D. Co-Founder, Chief Science Officer, and Project PI. Over 12 years of experience in gut microbiome and public health research. Ph.D. from the University of Arkansas, postdoc training at USDA ARS and Yale University.

Key Team

• Machine Learning Team:

Expertise in AI/ML applications for healthcare, featuring professionals like Dr. Jingjing Tong, Dr. Sean Wu, Dr. Zisu Hao, and Dr. Yaxin Zheng.

• Microbiome Team:

Multidisciplinary researchers focusing on gut microbiome sequencing and metabolomics, led by Dr. Young Min Kwon, Dr. Jiangchao Zhao, and others.

• Software Engineering Team:

Specialists Dr. Heng Liu and Dr. Tim He drive platform development for clinical integration.

• Consultants

Dr. Michael Lipcan (Gastroenterologist, Yale New Haven Hospital)

Dr. Andrew Hendifar (Medical Director, Cedars-Sinai)

Dr. Xiaoyong Yang (Professor, Yale University)

Dr. Stephen Freedland (Director, Cedars-Sinai Medical Center)

Dr. Pengda Liu (Professor, UNC – Chapel Hill)

“Committed to Innovation and Revolutionizing Disease Screening to Save More Lives”

Yichao Yang

CEO, Adora Tech L.L.C.